Table of Contents

1 RESEARCH SCOPE

• 1.1 Research Product Definition
• 1.2 Research Segmentation
  • 1.2.1 Product Type
  • 1.2.2 Main product Type of Major Players
• 1.3 Demand Overview
• 1.4 Research Methodology

2 GLOBAL RENAL DISEASE TREATMENT INDUSTRY

• 2.1 Summary about Renal Disease Treatment Industry
• 2.2 Renal Disease Treatment Market Trends
  • 2.2.1 Renal Disease Treatment Production & Consumption Trends
  • 2.2.2 Renal Disease Treatment Demand Structure Trends
• 2.3 Renal Disease Treatment Cost & Price

3 MARKET DYNAMICS

• 3.1 Manufacturing & Purchasing Behavior in 2020
• 3.2 Market Development under the Impact of COVID-19
  • 3.2.1 Drivers
  • 3.2.2 Restraints
  • 3.2.3 Opportunity
  • 3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

• 4.1 Region Segmentation (2017 to 2021f)
  • 4.1.1 North America (U.S., Canada and Mexico)
  • 4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
  • 4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
  • 4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
  • 4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
• 4.2 Product Type Segmentation (2017 to 2021f)
  • 4.2.1 Acute Kidney Problems
  • 4.2.2 Chronic Kidney Diseases
  • 4.2.3 Others
• 4.3 Consumption Segmentation (2017 to 2021f)
  • 4.3.1 Hospital
  • 4.3.2 Clinic
  • 4.3.3 Research Center
  • 4.3.4 Others

5 NORTH AMERICA MARKET SEGMENT

• 5.1 Region Segmentation (2017 to 2021f)
  • 5.1.1 U.S.
  • 5.1.2 Canada
  • 5.1.3 Mexico
• 5.2 Product Type Segmentation (2017 to 2021f)
  • 5.2.1 Acute Kidney Problems
  • 5.2.2 Chronic Kidney Diseases
  • 5.2.3 Others
• 5.3 Consumption Segmentation (2017 to 2021f)
  • 5.3.1 Hospital
  • 5.3.2 Clinic
  • 5.3.3 Research Center
  • 5.3.4 Others
• 5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

• 6.1 Region Segmentation (2017 to 2021f)
  • 6.1.1 Germany
  • 6.1.2 UK
  • 6.1.3 France
  • 6.1.4 Italy
  • 6.1.5 Rest of Europe
• 6.2 Product Type Segmentation (2017 to 2021f)
  • 6.2.1 Acute Kidney Problems
  • 6.2.2 Chronic Kidney Diseases
  • 6.2.3 Others
• 6.3 Consumption Segmentation (2017 to 2021f)
  • 6.3.1 Hospital
  • 6.3.2 Clinic
  • 6.3.3 Research Center
  • 6.3.4 Others
• 6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

• 7.1 Region Segmentation (2017 to 2021f)
  • 7.1.1 China
  • 7.1.2 India
  • 7.1.3 Japan
  • 7.1.4 South Korea
  • 7.1.5 Southeast Asia
  • 7.1.6 Australia
  • 7.1.7 Rest of Asia Pacific
• 7.2 Product Type Segmentation (2017 to 2021f)
  • 7.2.1 Acute Kidney Problems
  • 7.2.2 Chronic Kidney Diseases
  • 7.2.3 Others
• 7.3 Consumption Segmentation (2017 to 2021f)
  • 7.3.1 Hospital
  • 7.3.2 Clinic
  • 7.3.3 Research Center
  • 7.3.4 Others
• 7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

• 8.1 Region Segmentation (2017 to 2021f)
  • 8.1.1 Brazil
  • 8.1.2 Argentina
  • 8.1.3 Rest of Latin America
• 8.2 Product Type Segmentation (2017 to 2021f)
  • 8.2.1 Acute Kidney Problems
  • 8.2.2 Chronic Kidney Diseases
  • 8.2.3 Others
• 8.3 Consumption Segmentation (2017 to 2021f)
  • 8.3.1 Hospital
  • 8.3.2 Clinic
  • 8.3.3 Research Center
  • 8.3.4 Others
• 8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

• 9.1 Region Segmentation (2017 to 2021f)
  • 9.1.1 GCC
  • 9.1.2 North Africa
  • 9.1.3 South Africa
  • 9.1.4 Rest of Middle East and Africa
• 9.2 Product Type Segmentation (2017 to 2021f)
  • 9.2.1 Acute Kidney Problems
  • 9.2.2 Chronic Kidney Diseases
  • 9.2.3 Others
• 9.3 Consumption Segmentation (2017 to 2021f)
  • 9.3.1 Hospital
  • 9.3.2 Clinic
  • 9.3.3 Research Center
  • 9.3.4 Others
• 9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

• 10.1 Brief Introduction of Major Players
  • 10.1.1 Abbott
  • 10.1.2 Amgen
  • 10.1.3 Baxter
  • 10.1.4 Bristol-Myers Squibb Company
  • 10.1.5 Keryx Biopharmaceuticals
  • 10.1.6 NephroGenex
  • 10.1.7 Novartis AG
  • 10.1.8 Pfizer
  • 10.1.9 Sanofi
  • 10.1.10 Shire Pharmaceuticals Limited
  • 10.1.11 CTI BioPharma Corp
  • 10.1.12 Merck
  • 10.1.13 Prolong Pharmaceuticals
  • 10.1.14 VESSL Therapeutics
• 10.2 Renal Disease Treatment Sales Date of Major Players (2017-2020e)
  • 10.2.1 Abbott
  • 10.2.2 Amgen
  • 10.2.3 Baxter
  • 10.2.4 Bristol-Myers Squibb Company
  • 10.2.5 Keryx Biopharmaceuticals
  • 10.2.6 NephroGenex
  • 10.2.7 Novartis AG
  • 10.2.8 Pfizer
  • 10.2.9 Sanofi
  • 10.2.10 Shire Pharmaceuticals Limited
  • 10.2.11 CTI BioPharma Corp
  • 10.2.12 Merck
  • 10.2.13 Prolong Pharmaceuticals
  • 10.2.14 VESSL Therapeutics
• 10.3 Market Distribution of Major Players
• 10.4 Global Competition Segmentation

11 MARKET FORECAST

• 11.1 Forecast by Region
• 11.2 Forecast by Demand
• 11.3 Environment Forecast
  • 11.3.1 Impact of COVID-19
  • 11.3.2 Geopolitics Overview
  • 11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

List of Table

1.Table Renal Disease Treatment Product Type Overview

2.Table Renal Disease Treatment Product Type Market Share List

3.Table Renal Disease Treatment Product Type of Major Players

4.Table Brief Introduction of Abbott

5.Table Brief Introduction of Amgen

6.Table Brief Introduction of Baxter

7.Table Brief Introduction of Bristol-Myers Squibb Company

8.Table Brief Introduction of Keryx Biopharmaceuticals

9.Table Brief Introduction of NephroGenex

10.Table Brief Introduction of Novartis AG

11.Table Brief Introduction of Pfizer

12.Table Brief Introduction of Sanofi

13.Table Brief Introduction of Shire Pharmaceuticals Limited

14.Table Brief Introduction of CTI BioPharma Corp

15.Table Brief Introduction of Merck

16.Table Brief Introduction of Prolong Pharmaceuticals

17.Table Brief Introduction of VESSL Therapeutics

18.Table Products & Services of Abbott

19.Table Products & Services of Amgen

20.Table Products & Services of Baxter

21.Table Products & Services of Bristol-Myers Squibb Company

22.Table Products & Services of Keryx Biopharmaceuticals

23.Table Products & Services of NephroGenex

24.Table Products & Services of Novartis AG

25.Table Products & Services of Pfizer

26.Table Products & Services of Sanofi

27.Table Products & Services of Shire Pharmaceuticals Limited

28.Table Products & Services of CTI BioPharma Corp

29.Table Products & Services of Merck

30.Table Products & Services of Prolong Pharmaceuticals

31.Table Products & Services of VESSL Therapeutics

32.Table Market Distribution of Major Players

33.Table Global Major Players Sales Revenue (Million USD) 2017-2020e

34.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

35.Table Global Renal Disease Treatment Market Forecast (Million USD) by Region 2021f-2026f

36.Table Global Renal Disease Treatment Market Forecast (Million USD) Share by Region 2021f-2026f

37.Table Global Renal Disease Treatment Market Forecast (Million USD) by Demand 2021f-2026f

38.Table Global Renal Disease Treatment Market Forecast (Million USD) Share by Demand 2021f-2026f

List of Figure

1.Figure Global Renal Disease Treatment Market Size under the Impact of COVID-19, 2017-2021f (USD Million)

2.Figure Global Renal Disease Treatment Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)

3.Figure Global Renal Disease Treatment Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)

4.Figure Global Renal Disease Treatment Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)

5.Figure Global Renal Disease Treatment Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)

6.Figure Global Renal Disease Treatment Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)

7.Figure Global Renal Disease Treatment Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)

8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

13.Figure Acute Kidney Problems Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

14.Figure Chronic Kidney Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

15.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

16.Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

17.Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

18.Figure Research Center Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

19.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

20.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

21.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

22.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

23.Figure Acute Kidney Problems Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

24.Figure Chronic Kidney Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

25.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

26.Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

27.Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

28.Figure Research Center Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

29.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

30.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

31.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

32.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

33.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

34.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

35.Figure Acute Kidney Problems Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

36.Figure Chronic Kidney Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

37.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

38.Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

39.Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

40.Figure Research Center Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

41.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

42.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

43.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

44.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

45.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

46.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

47.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

48.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

49.Figure Acute Kidney Problems Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

50.Figure Chronic Kidney Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

51.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

52.Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

53.Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

54.Figure Research Center Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

55.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

56.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

57.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

58.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

59.Figure Acute Kidney Problems Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

60.Figure Chronic Kidney Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

61.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

62.Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

63.Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

64.Figure Research Center Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

65.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

66.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

67.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

68.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

69.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

70.Figure Acute Kidney Problems Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

71.Figure Chronic Kidney Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

72.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

73.Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

74.Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Renal Disease Treatment market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Renal Disease Treatment market segmented into
Acute Kidney Problems
Chronic Kidney Diseases
Others

Based on the end-use, the global Renal Disease Treatment market classified into
Hospital
Clinic
Research Center
Others

Based on geography, the global Renal Disease Treatment market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Abbott
Amgen
Baxter
Bristol-Myers Squibb Company
Keryx Biopharmaceuticals
NephroGenex
Novartis AG
Pfizer
Sanofi
Shire Pharmaceuticals Limited
CTI BioPharma Corp
Merck
Prolong Pharmaceuticals
VESSL Therapeutics